ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BPURD Biopure (MM)

0.00
0.00 (0.00%)
Pre Market
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biopure (MM) NASDAQ:BPURD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Biopure Appoints Officer and Regains Nasdaq Listing Compliance

17/10/2007 12:30pm

PR Newswire (US)


Biopure (MM) (NASDAQ:BPURD)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Biopure  (MM) Charts.
CAMBRIDGE, Mass., Oct. 17 /PRNewswire-FirstCall/ -- Biopure Corporation (NASDAQ:BPURDNASDAQ:BPUR) announced today that the board of directors has elected R. Todd Wood as the company's Vice President-Operations and Acting Chief Financial Officer. In addition, Biopure announced that it has received notification from The Nasdaq Stock Market that the company has regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Markets, pursuant to Marketplace Rule 4310(c)(4). As previously announced, CFO Francis H. Murphy, age 69, has advised the company of his intention to retire by December 14, 2007. Mr. Wood, age 35, has been a consultant to the company since earlier this year, serving as a director of business development. Mr. Wood's background includes founding and serving as CEO of a software company, financial consulting and advisory services with Morgan Stanley and Merrill Lynch and various other technology and systems positions. Mr. Wood holds the MBA cum laude from the University of Notre Dame. Mr. Murphy has agreed to remain at Biopure during a transition period. Biopure Corporation Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer -- 250 (bovine)], or HBOC-201, is being sold in South Africa for the treatment of surgical patients who are acutely anemic. Biopure's veterinary product Oxyglobin(R) [hemoglobin glutamer -- 200 bovine)], or HBOC-301, the only oxygen therapeutic approved by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure has sold approximately 186,000 units of Oxyglobin, which have been used to treat an estimated 100,000 animals. Contact: Tiana Gorham Biopure Corporation (617) 234-6826 DATASOURCE: Biopure Corporation CONTACT: Tiana Gorham of Biopure Corporation, +1-617-234-6826, Web site: http://www.biopure.com/ Company News On-Call: http://www.prnewswire.com/comp/131224.html

Copyright

1 Year Biopure (MM) Chart

1 Year Biopure  (MM) Chart

1 Month Biopure (MM) Chart

1 Month Biopure  (MM) Chart

Your Recent History

Delayed Upgrade Clock